22 Percent: What the New Kidney Disease Number for Black Adults Actually Means

Deep-research Numbers article on chronic kidney disease, explaining one disparity statistic with its definition, denominator, and limits. In CDC's Chronic Kidney Disease in the United States, updated March 2026 (NHANES August 2021-August 2023, CKD stages 1-4, CKD-EPI equation without race, single UACR/creatinine measure), CKD prevalence was 22% among non-Hispanic Black adults aged 18 and older versus 13% among non-Hispanic White adults and 12% among Hispanic adults; overall 14% (37 million). The article compares the previous 2023 report (about 20% vs about 12%, NHANES 2017-March 2020, 35.5 million), explains the race-free equation and methods change, reports awareness (87% of adults 20+ with CKD did not know), the diabetes (38%) and hypertension (21%) denominators, and the kidney-failure end from USRDS 2025 (131,564 started treatment in 2023; 831,192 living with ESKD; Black incidence 4x White). Supplement trials (berberine biomarkers, n=69; omega-3 in hemodialysis) are used only as a scale check. No supplement claim, recommendation, or product is made; kidney high-care box included. Evidence grade: STRONG. Educational article from the Buddha Ayurvedic School of Medicine: https://buddha.hospital

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24345366
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

22 Percent: What the New Kidney Disease Number for Black Adults Actually Means

Ajarn Shaman Shu
Zenodo (CERN European Organization for Nuclear Research)
Chronic Kidney Disease and Diabetes
article

22 Percent: What the New Kidney Disease Number for Black Adults Actually Means

Ajarn Shaman Shu
article en

Abstract

Deep-research Numbers article on chronic kidney disease, explaining one disparity statistic with its definition, denominator, and limits. In CDC's Chronic Kidney Disease in the United States, updated March 2026 (NHANES August 2021-August 2023, CKD stages 1-4, CKD-EPI equation without race, single UACR/creatinine measure), CKD prevalence was 22% among non-Hispanic Black adults aged 18 and older versus 13% among non-Hispanic White adults and 12% among Hispanic adults; overall 14% (37 million). The article compares the previous 2023 report (about 20% vs about 12%, NHANES 2017-March 2020, 35.5 million), explains the race-free equation and methods change, reports awareness (87% of adults 20+ with CKD did not know), the diabetes (38%) and hypertension (21%) denominators, and the kidney-failure end from USRDS 2025 (131,564 started treatment in 2023; 831,192 living with ESKD; Black incidence 4x White). Supplement trials (berberine biomarkers, n=69; omega-3 in hemodialysis) are used only as a scale check. No supplement claim, recommendation, or product is made; kidney high-care box included. Evidence grade: STRONG. Educational article from the Buddha Ayurvedic School of Medicine: https://buddha.hospital

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being, Reduced inequalities
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon